log in
Print | Back

Cechova & Partners

Marek Holka

Marek Holka



  • Administrative Law
  • Antitrust and Unfair Competition
  • Commercial Law
  • Corporate and Business

WSG Practice Industries


WSG Leadership

WSG Coronavirus Task Force Group
Marek graduated from the Comenius University in Bratislava, Faculty of Law, and received his master in 2011. During his studies, he attended a study program in Lund University in Sweden, where he dealt mostly with EU law and competition law. In 2010 he completed an internship with the Antimonopoly Office of the Slovak Republic, where he dealt predominantly with the possibilities of private enforcement of competition law.

In 2011, Marek became an associate in Cechova & Partners, where he already worked as a student. He has been involved in advising several multinational companies in antitrust proceedings at the Slovak national competition authority and regularly advises clients on antitrust compliance issues. Marek is also regularly involved in the merger control cases. During his practice, he also gained relevant experience in regulatory issues, including banking, insurance, reinsurance, payment services, electronic money, collective investment and securities-related matters.

Bar Admissions

Slovak Bar Association


Law Faculty of Comenius University, Bratislava, Slovakia (Graduated, M.A., 2011)
Faculty of Law of Lund University, Sweden (Program in EU and Competition Law, 2010 - 2011)
Areas of Practice

Administrative Law | Antitrust and Unfair Competition | Commercial Law | Corporate and Business

Professional Career

Professional Activities and Experience

Cechova & Partners (2006-2009, 2011)

COVID-19 Measures in the Healthcare Sector: Update
Cechova & Partners, April 2020

Since the publication of our legal update on COVID-19 Legal Challenges for Pharmaceutical Companies on 31 March 2020, new important measures were adopted or announced on both national and EU level...

COVID-19: Legal Challenges for Pharmaceutical Companies
Cechova & Partners, March 2020

Pharmaceutical companies are meeting with numerous legal challenges resulting from the ongoing COVID-19 pandemic and the corresponding Government measures. Among the most discussed topics are the legal obligations relating to availability of medicinal products, securing of medicinal products for treatment of patients with COVID-19, control over the distribution channel, clinical trials, and relations with healthcare professionals...

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021